Neiratax

Medicinal product

(Invented) name

Neiratax

Active substance (s)

Piridoksino hidrochloridas/Tiamino hidrochloridas/Cianokobalaminas/Lidokaino hidrochloridas

Strength

100 mg/100 mg/1 mg/20 mg/2 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

A11DB, Vitamin B1 in combination with vitamin B6 and/or vitamin B12

Marketing authorisation holder

AS Kalceks, Latvija

Date of authorisation

2017-09-12

Date of renewal

2022-04-04

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

EE/H/0239/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Ampulėje (2 ml) yra	2 ml
Piridoksino hidrochloridas	100 mg
Tiamino hidrochloridas	100 mg
Cianokobalaminas	1 mg
Lidokaino hidrochloridas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
97714	83809	1083809	ampulė	2 ml N5	Receptinis	LT/1/17/4132/001	Tiekiama	-	-	No	-	-	Download
97715	83810	1083810	ampulė	2 ml N10	Receptinis	LT/1/17/4132/002	Netiekiama	-	-	No	-	-
97716	83811	1083811	ampulė	2 ml N25	Receptinis	LT/1/17/4132/003	Tiekiama	2024-12-29	-	No	-	-

Stadijos

Data	Stadija
2022-04-04	Perregistruotas
2017-09-12	Registruotas